← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2014Last known activity
Oct 15, 2024
Timeline
1990s
- Jun 1, 1993
Vinmec International Hospital— Founded
Drugs by trial phase (13 distinct, 31 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
- imatinib
- allogeneic adipose derived mesenchymal stem cell
- umbilical cord mesenchymal stem cells
- autologous bone marrow derived mesenchymal cells
- autologous mononuclear stem cell
- piperaquine
- dihydroartemisinin
- autologous hematopoietic stem cells
- autologous adipose-derived mesenchymal stem cells
- COVID-19 convalescent plasma
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Autistic Disorder
- Biliary Atresia
- Bronchopulmonary Dysplasia
- Cerebral Palsy
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Encephalitis
- Endocrine System Diseases
- Fibrosis
- Hyperplasia
- Jaundice
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Lung Diseases, Obstructive
- Malaria, Falciparum
- Meningitis
- Paralysis
- Pulmonary Disease, Chronic Obstructive
Recent trials (50)
- NCT06629324OfficialPhase 2Oct 15, 2024
- NCT06629324Lead sponsorPhase 2Oct 15, 2024
- NCT06726538Lead sponsorPhase 1/Phase 2Oct 1, 2023
- NCT06726538OfficialPhase 1/Phase 2Oct 1, 2023
- NCT06027957Overall official - principal investigatorPhase 1Aug 2, 2023
- NCT06027957Lead sponsorPhase 1Aug 2, 2023
- NCT05329662Lead sponsorPhase 2Nov 1, 2022
- NCT05345418Lead sponsorPhase 1/Phase 2Jun 1, 2022
- NCT05307536Lead sponsorPhase 2Dec 26, 2021
- NCT05307536Overall official - principal investigatorPhase 2Dec 26, 2021
- NCT05308836Lead sponsorPhase 1Oct 4, 2021
- NCT05308836Overall official - principal investigatorPhase 1Oct 4, 2021
- NCT05308836OfficialPhase 1Oct 4, 2021
- NCT05292625Overall official - principal investigatorPhase 1/Phase 2Jul 15, 2021
- NCT05292625Lead sponsorPhase 1/Phase 2Jul 15, 2021
Details
- Founded
- Hanoi, VN Jun 1, 1993
- Last known activity
- Oct 15, 2024